Abiopharma

🔍 COOK TIMOTHY D (Director)

Company: NIKE, Inc. (NKE)

Report Date: 2026-04-10

Detailed Transactions and Holdings:

• Acquired 25,000 shares of Class B Common Stock at $42.43 per share (Direct)
  Date: 2026-04-10 | Code: P | equity_swap_involved: 0 | shares_owned_after: 130,480.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.42 to $42.44, inclusive. The reporting person undertakes to provide NIKE, Inc., any security holder of NIKE, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote (2) to this Form 4.